Stock Market & Financial Investment News

News Breaks February 19, 2013 11:15 EDT GHDX Genomic Health Oncotype DX recommended in NICE guidance The U.K.'s National Institute for Health and Clinical Excellence, or NICE, issued draft guidance on four tests used to guide decisions about the use of chemotherapy in people with early breast cancer following consultations on previous drafts and the submission of a confidential access proposal by the manufacturer of Oncotype DX, Genomic Health (GHDX). The draft guidance recommends the use of Oncotype DX in people with oestrogen receptor positive, lymph node negative and human epidermal growth factor receptor 2 negative early breast cancer, who are assessed as being at intermediate risk, to guide chemotherapy decisions where the manufacturer provides it at the price offered through the confidential access proposal. The recommendation for Oncotype DX applies to people assessed as being at intermediate risk of distant recurrence by decision making tools/protocols currently in use in the NHS and where the decision to prescribe chemotherapy remains unclear, NICE said. The draft guidance also highlights that it has not been able to support the routine use of the IHC4, MammaPrint or Mammostrat tests but recommends that they are used in a research setting to collect evidence about potentially important clinical outcomes and to determine the ability of the tests to predict the efficacy of chemotherapy in people with early breast cancer. Reference Link News For GHDX From The Last 14 Days Check below for free stories on GHDX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 14, 2013 12:00 EDT GHDX Myriad Genetics climbs after Jolie reveals genetic testing Subscribe for More Information May 13, 2013 16:42 EDT GHDX Genomic Health files to sell 10M shares of common stock May 10, 2013 16:04 EDT GHDX Genomic Health announces expanded Medicare coverage for Oncotype DX test Subscribe for More Information May 8, 2013 05:32 EDT GHDX Genomic Health announces availability of Oncotype DX Subscribe for More Information May 6, 2013 07:26 EDT GHDX American Urological Association to host annual meeting Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.